Telix Pharmaceuticals (TLX) Long-Term Investments (2024 - 2025)
Telix Pharmaceuticals (TLX) posted Long-Term Investments of $342.43 million for the quarter ended Dec 31, 2025, up 80.8% from $189.36 million a year earlier.
Powered by 
Analysis
Telix Pharmaceuticals (TLX) Long-Term Investments (2024 - 2025) Analysis & Trends
- In prior years, Telix Pharmaceuticals' Long-Term Investments was $189.36 million in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,333.71 Bn | 1,307.33 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 665.21 Bn | 585.07 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.27 Bn | 489.32 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 370.99 Bn | 325.42 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 314.75 Bn | 288.32 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 293.18 Bn | 267.16 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 258.67 Bn | 214.07 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 216.53 Bn | 191.55 Bn | 6.73 Bn | - |
| 9 | Pfizer | 175.50 Bn | 123.16 Bn | 12.56 Bn | 1.45 Bn |
| 10 | Telix Pharmaceuticals | 3.28 Bn | 2.24 Bn | - | - |
API Access
Telix Pharmaceuticals Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=TLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "TLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=TLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();